Workshops

Workshops

IPVC 2021 workshops will focus on this year’s theme, “Research and education for HPV elimination”. They will provide state-of-the-art knowledge on all papillomavirus (PV)-related topics, from basic science to global health impact.

Workshops will be run by and have speakers who are worldwide leaders in the field. They will provide a unique forum for education and discussion, for the full spectrum of professional audiences – junior through senior researchers; basic scientists, clinicians and public health investigators.

At IPVC 2021, the pre-conference workshops will be made up of two parts:

  • The first day will start with an interdisciplinary workshop, consisting of a series of talks covering key aspects of basic science, clinical and public health, with plenty of opportunities for discussion and audience interaction.
  • Afterwards, attendees will be able to join one of the three tracks – Basic Science, Clinical Science or Public Health, Epidemiology and Implementation Science – where specific topics of contemporary interest will be covered. A particular emphasis will be given to discussion on controversial areas of research and on experiences across different populations. In all sessions, audience interaction will be prioritized.

Monday, November 15, 2021

Click on the sections below to learn more about the workshops. Please note the information might be subject to change.

10:00 AM – 11:30 AM EST (​GMT-4)

Moderator:

Silvia de Sanjosé, Spain

Presentations:

  • High risk HPV infection – the molecular road to cancer
    Karl Munger, USA
  • HPV-specific medical therapies- prospects and challenges
    Jacques Archambault, Canada
  • Increased burden of HPV cancers: another collateral damage of the COVID-19 pandemic?
    Karen Canfell, Australia
  • On the road to cervical cancer elimination: obstacles, challenges and opportunities
    Ophelia Ginsburg, USA

12:00 PM – 01:30 PM EST (​GMT-4)

BASIC SCIENCE WORKSHOP 01: THE BIOLOGY OF HUMAN PAPILLOMAVIRUS DISEASE AT THE CERVIX

Chair:

John Doorbar, UK

Presentations:

  • The Cervical Transformation Zone – Understanding Disease Pathology at a Vulnerable Epithelial Site
    Olaf Reich, Austria
  • HPV Deregulation and the Pathways towards Cervical Neoplasia and Cancer
    John Doorbar, UK

  • Immune Control of Human Papillomavirus – Current Thinking and Gaps in Our Knowledge
    John Schiller, USA

  • Factors Influencing Cervical Cancer Progression Risk. Key Perspectives from the Epidemiologist
    Mark Schiffman, USA

02:00 PM – 03:30 PM EST (​GMT-4)

BASIC SCIENCE WORKSHOP 02: VIRUS ENTRY AND TRAFFICKING

Chair:

John Doorbar, UK

Presentations:

  • HPV16 Pseudovirus Infection is Blocked by a Peptide Derived from Sorting Nexin-1
    Samuel K. Campos, USA

  • Going fishing with HPV during virus entry
    Dan DiMaio, USA

  • HPV16 uptake by WASH-mediated endocytosis (WASH-ME)
    Mario Schelhaas, Germany

  • Nuclear delivery of HPV16 capsids
    Patricia Day, USA

  • Nuclear phospholipases facilitate HPV16 infection
    Martin Sapp, USA

04:00 PM – 05:30 PM EST (​GMT-4)

BASIC SCIENCE WORKSHOP 03: GENOME STRUCTURE AND EXPRESSION

Chairs:

Alison McBride, USA
Joanna Parish, UK

Presentations:

  • Dynamic expression of the diversified papillomavirus genomes
    Zhi-Ming Zheung, USA
  • Genome-wide epigenetic modifications in papillomavirus genome expression
    Joanna Parish, UK
  • RNA-cis elements in papillomavirus RNA splicing and gene expression
    Stefan Schwartz, Sweden
  • Integrated HPV genome structure and clonal selection
    Dr. Lulu Yu, USA

12:00 PM – 01:30 PM EST (​GMT-4)

CLINICAL RESEARCH WORKSHOP 01: UPDATE ON EPIDEMIOLOGY OF HPV-RELATED CANCER AND PRE-CANCER

Chairs:

Silvia de Sanjose, Spain
Ashish Deshmukh, USA

Presentations:

  • Updates in the epidemiology of cervical cancer and pre-cancer
    Silvia de Sanjose, Spain
  • Updates in the epidemiology of head and neck cancer and pre-cancer
    Gypsyamber (Amber) D’Souza, USA
  • Updates in the epidemiology of anal cancer and pre-cancer 
    Ashish Deshmukh, USA
  • Updates in the epidemiology of other HPV-related cancers
    Gary Clifford, France
  • Debate – It is time to change cervical screening practices for women who have been vaccinated against HPV?

2:00 PM – 03:30 PM EST (​GMT-4)

CLINICAL RESEARCH WORKSHOP 02: EMERGING APPROACHES TO IMMUNOTHERAPY OF PRE-CANCER AND CANCER

Chair:

Mark Einstein, USA

Presentations:

  • TBC
    Peter Stern, UK
  • Update on therapeutic vaccines
    Andrew (Andy) G. Sikora, USA
  • Therapeutic uses of prophylactic HPV vaccines
    John Schiller, USA
  • Role of checkpoint inhibitors
    Mark Einstein, USA
  • Debate – Immunotherapy is better targeted at invasive cancer than high-grade squamous intraepithelial lesions
    Pro: Sjoerd van der Burg, The Netherlands

    Con: Kees Cornelis Melief, The Netherlands

04:00 PM – 04:50 PM EST (​GMT-4)

CLINICAL RESEARCH WORKSHOP 03: DIAGNOSIS AND MANAGEMENT OF HPV-RELATED DISEASE IN THE IMMUNOCOMPROMISED PATIENT

Chairs:

Joel Palefsky, USA
Meredith Shiels, USA

Presentations:

  • Epidemiology of HPV-related cancer in the immunocompromised host
    Meredith Shiels, USA
  • Diagnosis of HPV-related disease in the immunocompromised patient: special considerations
    Richard Hillman, Australia
  • Management of HPV-related disease in the immunocompromised patient: special considerations
    Elizabeth Stier, USA
  • Vaccination for prevention and treatment of the immunocompromised patient: special considerations
    Joel Palefsky, USA

12:00 PM – 01:30 PM EST (​GMT-4)

PUBLIC HEALTH WORKSHOP 01: VACCINATION

Chair:

Julia Brotherton, Australia

Presentations:

  • State of the art in vaccine coverage
    Paul Bloem, Switzerland
  • Debate: Gender neutral vaccination
    Pro: Iacobo Bausano
    Con: Helen Riess, USA
  • Measuring impact in LMIC: the importance of information and surveillance systems
    Raúl Murillo, Colombia
  • New prophylactic vaccines
    Peter Dull, USA
  • Panel: One dose vs two doses
    Scott D. Lamontagne
    Deborah Watson-Jones, UK
    Aimée Kreimer, USA

02:00 PM – 03:30 PM EST (​GMT-4)

PUBLIC HEALTH WORKSHOP 02: SCREENING

Chair:

Mark Steben, Canada

Presentations:

  • Self-sampling
    Gina Ogilvie, Canada
  • Comprehensive coverage
    Laia Bruni, Spain
  • Triage strategies in LMIC: should we use risk-based management?
    Mark Schiffman, USA
  • Reaching unreached population
    Aisha Lofters, Canada
  • Treatment issues
    Michael Chang

04:00 PM – 04:50 PM EST (​GMT-4)

PUBLIC HEALTH WORKSHOP 03: INFORMATION AND EDUCATION

Chair:

Ana Cecilia Rodriguez, USA

Presentations:

  • Vaccinating against misinformation
    Heidi Larson, UK
  • Education of healthcare professionals
    Silvina Arrossi, Argentina
  • Complex system approach as optimal strategy for control?
    Patti Gravitt, USA

Tuesday, November 16, 2021

Click on the sections below to learn more about the workshops. Please note the information might be subject to change.

10:30 AM – 12:00 PM EST (​GMT-4)

BASIC SCIENCE WORKSHOP 04: REPLICATION

Chairs:

Alison McBride, USA
Joanna Parish, UK

Presentations:

  • Viral factors and HPV replication
    Dr. Iain Morgan, UK
  • The role of the DDR and epigenetic factors in HPV replication
    Cary Moody, USA
  • Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
    Lisa Mirabello, USA

12:30 PM – 14:00 PM EST (​GMT-4)

BASIC SCIENCE WORKSHOP 05: MOLECULAR BASIS OF ANTIVIRALS FOR HPV

Chairs:

Michelle Ozbun, USA
Prof. Sheila Graham, UK

Presentations:

  • Therapeutic vaccines
    Martin Kast, USA

  • Viral replication
    Alison McBride, USA

  • Innate immune response
    Marisa Gariglio, Italy

  • Cell signalling
    Andrew MacDonald, UK

10:30 AM – 12:00 PM EST (​GMT-4)

CLINICAL RESEARCH WORKSHOP 04: EMERGING CONCEPTS IN PATHOGENESIS AND DIAGNOSIS OF HPV-RELATED CANCER AND PRE-CANCER

Chairs:

Robert Burk, USA
Nicolas Wentzensen, USA

Presentations:

  • Role of microRNAs and incRNAs in pathogenesis of HPV-related disease
    Thomas Zheng, USA
  • Role of microbiome in pathogenesis of HPV-related disease
    Maria Kyrgiou, UK
  • Artificial Intelligence-Based Triage Strategies: Dual Stain and Automated Visual Evaluation
    Nicolas Wentzensen, USA
  • DNA sequencing for detection of HPV
    Lisa Mirabello, USA
  • Methylation panel discussion
    Robert Burk, USA
    Attila Lorincz, UK
    Renske Steenbergen, The Netherlands

12:30 PM – 02:00 PM EST (​GMT-4)

CLINICAL RESEARCH WORKSHOP 05: HPV PROPHYLACTIC VACCINATION UPDATE

Chair:

Margaret Stanley, UK
Francesc Xavier Bosch, Spain

Presentations:

  • Trends in vaccine uptake: impact of the Covid pandemic
    Francesco Xavier Bosch, Spain
  • Impact of HPV vaccination on cervical cancer, pre-cancer and HPV
    Marc Brisson, Canada
  • Durability of HPV vaccine response
    Anna Giuliano, USA
  • New vaccine candidates
    Richard Roden, USA
  • Debate: Gender neutral vaccination should be standard in all countries where HPV vaccination is standard of care for females
    Pro: Margaret Stanley, UK
    Con: John Schiller, USA

10:30 PM – 12:00 PM EST (​GMT-4)

PUBLIC HEALTH WORKSHOP 04: COMBINATION STRATEGIES

Chair:

Louise Kuhn, USA

Presentations:

  • Considerations for the adequate clinical assessment of AI based approaches in image evaluation
    Kanan Desai, USA
  • Combined strategy for cervical cancer control: Even Faster program
    Joakim Dillner, Sweden
  • HIV, Female genital schistosomiasis and bacterial vaginosis: cervical cancer forgotten companions?
    Peter Hotez, USA
  • Is there a place for services integration?
    Ruanne Barnabas, USA
  • Financing HPV testing and thermocoagulation
    Owen Demke, Rwanda

12:30 PM – 02:00 PM EST (​GMT-4)

PUBLIC HEALTH WORKSHOP 05: FORGOTTEN ISSUE IN THE CERVICAL ELIMINATION DRIVE

Chair:

Marc Steben, Canada

Presentations:

  • Upgrading surgical capacities for cancer treatment in LMIC
    Partha Basu, France
  • Upgrading chemotherapy capacities in LMIC
    Neerja Bhatla, India
  • Upgrading radiotherapy capacities in LMIC
    Surbhi Grover, USA
  • Introduction of palliative care as integral part of cervical cancer elimination drive
    Eduardo D. Bruera, USA
  • Call to action
    Silvia de Sanjose, USA

Although workshops stand alone as an educational and scientific activity, they are designed to provide the necessary scientific background to follow the main conference, where the latest knowledge in research will be presented. For junior scientists, the workshops will help them to be educated on both the basics and cutting-edge knowledge of papillomavirus biology, epidemiology, and prevention and control of papillomavirus infection and disease.

IPVC 2021 workshops will be a unique way to connect across the fields, and attendees will enjoy PV research from different perspectives and participate in wider scientific discussions.

Please, note that there is an additional fee to attend the workshops and a pre-registration is required. For more information, visit the registration page.

If you have already registered and you wish to book a spot at the workshop, please contact reg_ipvc21@kenes.com